90 related articles for article (PubMed ID: 22887215)
21. Treatment with a Small Synthetic Compound, KMU-193, induces Apoptosis in A549 Human Lung Carcinoma Cells through p53 Up-Regulation.
Choi EY; Shin KC; Lee J; Kwon TK; Kim S; Park JW
Asian Pac J Cancer Prev; 2015; 16(14):5883-7. PubMed ID: 26320467
[TBL] [Abstract][Full Text] [Related]
22. A synthetic naringenin derivative, 5-hydroxy-7,4'-diacetyloxyflavanone-N-phenyl hydrazone (N101-43), induces apoptosis through up-regulation of Fas/FasL expression and inhibition of PI3K/Akt signaling pathways in non-small-cell lung cancer cells.
Bak Y; Kim H; Kang JW; Lee DH; Kim MS; Park YS; Kim JH; Jung KY; Lim Y; Hong J; Yoon DY
J Agric Food Chem; 2011 Sep; 59(18):10286-97. PubMed ID: 21877710
[TBL] [Abstract][Full Text] [Related]
23. Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells.
Ko JC; Ciou SC; Jhan JY; Cheng CM; Su YJ; Chuang SM; Lin ST; Chang CC; Lin YW
Mol Cancer Res; 2009 Aug; 7(8):1378-89. PubMed ID: 19671683
[TBL] [Abstract][Full Text] [Related]
24. SH-5, an AKT inhibitor potentiates apoptosis and inhibits invasion through the suppression of anti-apoptotic, proliferative and metastatic gene products regulated by IkappaBalpha kinase activation.
Sethi G; Ahn KS; Sung B; Kunnumakkara AB; Chaturvedi MM; Aggarwal BB
Biochem Pharmacol; 2008 Dec; 76(11):1404-16. PubMed ID: 18606397
[TBL] [Abstract][Full Text] [Related]
25. Sanguinarine induces apoptosis in A549 human lung cancer cells primarily via cellular glutathione depletion.
Jang BC; Park JG; Song DK; Baek WK; Yoo SK; Jung KH; Park GY; Lee TY; Suh SI
Toxicol In Vitro; 2009 Mar; 23(2):281-7. PubMed ID: 19135517
[TBL] [Abstract][Full Text] [Related]
26. The multi-target drug BAI induces apoptosis in various human cancer cells through modulation of Bcl-xL protein.
Kim S; Kim DE; Kwon TK; Lee J; Park JW
Int J Oncol; 2016 Dec; 49(6):2620-2628. PubMed ID: 27840907
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of Par-4 enhances thapsigargin-induced apoptosis via down-regulation of XIAP and inactivation of Akt in human renal cancer cells.
Lee TJ; Lee JT; Kim SH; Choi YH; Song KS; Park JW; Kwon TK
J Cell Biochem; 2008 Feb; 103(2):358-68. PubMed ID: 18041764
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxicity of a non-cyclooxygenase-2 inhibitory derivative of celecoxib in non-small-cell lung cancer A549 cells.
Tong Z; Wu X; Chen CS; Kehrer JP
Lung Cancer; 2006 Apr; 52(1):117-24. PubMed ID: 16497409
[TBL] [Abstract][Full Text] [Related]
29. FPDHP, a novel anticancer agent, induces cell detachment and caspase-dependent apoptosis in Caki cells.
Park JS; Kim WT; Kim S; Kwon TK; Jang BC; Lee ES; Park JW
Int J Mol Med; 2014 Oct; 34(4):1051-6. PubMed ID: 25092524
[TBL] [Abstract][Full Text] [Related]
30. AMP-activated protein kinase (AMPK) activation is involved in chrysin-induced growth inhibition and apoptosis in cultured A549 lung cancer cells.
Shao JJ; Zhang AP; Qin W; Zheng L; Zhu YF; Chen X
Biochem Biophys Res Commun; 2012 Jul; 423(3):448-53. PubMed ID: 22659738
[TBL] [Abstract][Full Text] [Related]
31. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells.
Nguyen TT; Tran E; Nguyen TH; Do PT; Huynh TH; Huynh H
Carcinogenesis; 2004 May; 25(5):647-59. PubMed ID: 14688022
[TBL] [Abstract][Full Text] [Related]
32. Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells: limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathways.
Janmaat ML; Kruyt FA; Rodriguez JA; Giaccone G
Clin Cancer Res; 2003 Jun; 9(6):2316-26. PubMed ID: 12796401
[TBL] [Abstract][Full Text] [Related]
33. Mahanine inhibits growth and induces apoptosis in prostate cancer cells through the deactivation of Akt and activation of caspases.
Sinha S; Pal BC; Jagadeesh S; Banerjee PP; Bandyopadhaya A; Bhattacharya S
Prostate; 2006 Sep; 66(12):1257-65. PubMed ID: 16683271
[TBL] [Abstract][Full Text] [Related]
34. HY253, a novel decahydrofluorene analog, from Aralia continentalis, induces cell cycle arrest at the G1 phase and cytochrome c-mediated apoptosis in human lung cancer A549 cells.
Oh HL; Lee DK; Lim H; Lee CH
J Ethnopharmacol; 2010 May; 129(1):135-9. PubMed ID: 20219657
[TBL] [Abstract][Full Text] [Related]
35. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
Hsu YL; Cho CY; Kuo PL; Huang YT; Lin CC
J Pharmacol Exp Ther; 2006 Aug; 318(2):484-94. PubMed ID: 16632641
[TBL] [Abstract][Full Text] [Related]
36. AKT serine/threonine protein kinase modulates bufalin-triggered intrinsic pathway of apoptosis in CAL 27 human oral cancer cells.
Tsai SC; Lu CC; Lee CY; Lin YC; Chung JG; Kuo SC; Amagaya S; Chen FN; Chen MY; Chan SF; Yang JS
Int J Oncol; 2012 Nov; 41(5):1683-92. PubMed ID: 22922805
[TBL] [Abstract][Full Text] [Related]
37. Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair.
Toulany M; Kehlbach R; Florczak U; Sak A; Wang S; Chen J; Lobrich M; Rodemann HP
Mol Cancer Ther; 2008 Jul; 7(7):1772-81. PubMed ID: 18644989
[TBL] [Abstract][Full Text] [Related]
38. 20(S)-protopanaxadiol triggers mitochondrial-mediated apoptosis in human lung adenocarcinoma A549 cells via inhibiting the PI3K/Akt signaling pathway.
Zhang YL; Zhang R; Xu HL; Yu XF; Qu SC; Sui DY
Am J Chin Med; 2013; 41(5):1137-52. PubMed ID: 24117074
[TBL] [Abstract][Full Text] [Related]
39. Chrysin-induced apoptosis is mediated through caspase activation and Akt inactivation in U937 leukemia cells.
Woo KJ; Jeong YJ; Park JW; Kwon TK
Biochem Biophys Res Commun; 2004 Dec; 325(4):1215-22. PubMed ID: 15555556
[TBL] [Abstract][Full Text] [Related]
40. Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-amine (A443654) in T-cell acute lymphoblastic leukemia.
Falà F; Blalock WL; Tazzari PL; Cappellini A; Chiarini F; Martinelli G; Tafuri A; McCubrey JA; Cocco L; Martelli AM
Mol Pharmacol; 2008 Sep; 74(3):884-95. PubMed ID: 18577685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
